Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Faucet set
D280232 Faucet set

Patent Drawings:
Inventor: Paul
Date Issued: August 20, 1985
Application: 06/488,577
Filed: April 25, 1983
Inventors: Paul; Stanley M. (Rye, NY)
Assignee: Paul Associates, Inc. (Long Island City, NY)
Primary Examiner: Largen; James R.
Assistant Examiner:
Attorney Or Agent: Blum, Kaplan, Friedman, Silberman & Beran
U.S. Class: D23/242
Field Of Search: D23/23; D23/24; D23/25; D23/26; D23/27; D23/28; D23/29; D23/30; D23/31; D23/32; 4/191; 4/192; 137/606; 137/801; 251/155
International Class:
U.S Patent Documents: D149388; D265229; D265230; D265231; D271513; D271514; D271704; 4290445
Foreign Patent Documents:
Other References:

Abstract:
Claim: The ornamental design for a faucet set, as shown.
Description: FIG. 1 is a front perspective view of a faucet set showing my new design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a front elevational view thereof;

FIG. 4 is a side elevational view thereof;

FIG. 5 is a rear elevational view thereof; and

FIG. 6 is a bottom plan view thereof.

* * * * *
 
 
  Recently Added Patents
Apparatus and method for controlling engine windmilling
Electric coil or power inverter
Method of fabricating metal oxide semiconductor field effect transistor
Method for forming recessed gate structure with stepped profile
Method and apparatus for registration of an imaged lithographic plate
Golf club head
Selecting between dominant and non-dominant motion vector predictor polarities
  Randomly Featured Patents
Self-supporting sheet-like structure having at least one structured surface
Discharge valve and baffle assembly for a refrigeration system
Joint for plastic lined light-weight metal piping
Tricyclic vasopressin agonists
Electrostatic recording material and method for the production thereof
Portable inflatable shelter and method of erection thereof
Escalator or moving walkway
Cyclone dust-separating apparatus with discharge electrodes
Electronic game housing
Methods of imaging cancer cells using modified C-reactive protein